<a href="https://www.fiercebiotech.com/biotech/chinas-oricell-raises-100m-carcinoma-car-t-plans-ahead-ipo-push" hreflang="en">China’s Oricell raises $110M for carcinoma CAR-T plans ahead of IPO push</a>
fiercebiotech.com·Apr 10, 2026
Oricell Therapeutics has successfully raised over $110 million in its final funding round as it prepares to go public with its CAR-T therapy in China.
For a professional tracking biotech IPOs and investments, Oricell Therapeutics' successful $110 million funding round indicates strong investor confidence and positions the company as a noteworthy player in the CAR-T therapy space, potentially making it a strategic opportunity for investment or partnership before its anticipated public offering.